Women Health Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: W96C7C27F71FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Women Health Therapeutics in Global, including the following market information:

Global Women Health Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Women Health Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Menopause Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Women Health Therapeutics include Novartis, Abbott, Pfizer, Eli Lilly, Bayer, Merck, Roche, Novo Nordisk and Oasmia, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Women Health Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Women Health Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Women Health Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Menopause
• Endometriosis
• Postmenopausal osteoporosis
• Breast cancer
• Polycystic ovary syndrome
• Infertility
• Gynecological cancer

Global Women Health Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Women Health Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Diagnostic and imaging centers
• Hospitals and clinics
• Home care

Global Women Health Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Women Health Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Women Health Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Women Health Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Abbott
• Pfizer
• Eli Lilly
• Bayer
• Merck
• Roche
• Novo Nordisk
• Oasmia
• Sanofi
• Takeda
• Allergan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Women Health Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Women Health Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL WOMEN HEALTH THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Women Health Therapeutics Market Size: 2021 VS 2028
2.2 Global Women Health Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Women Health Therapeutics Players in Global Market
3.2 Top Global Women Health Therapeutics Companies Ranked by Revenue
3.3 Global Women Health Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Women Health Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Women Health Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Women Health Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Women Health Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Women Health Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Women Health Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Menopause
  4.1.3 Endometriosis
  4.1.4 Postmenopausal osteoporosis
  4.1.5 Breast cancer
  4.1.6 Polycystic ovary syndrome
  4.1.7 Infertility
  4.1.8 Gynecological cancer
4.2 By Type - Global Women Health Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Women Health Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Women Health Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Women Health Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Women Health Therapeutics Market Size, 2021 & 2028
  5.1.2 Diagnostic and imaging centers
  5.1.3 Hospitals and clinics
  5.1.4 Home care
5.2 By Application - Global Women Health Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Women Health Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Women Health Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Women Health Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Women Health Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Women Health Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Women Health Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Women Health Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Women Health Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Women Health Therapeutics Revenue, 2017-2028
  6.3.2 US Women Health Therapeutics Market Size, 2017-2028
  6.3.3 Canada Women Health Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Women Health Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Women Health Therapeutics Revenue, 2017-2028
  6.4.2 Germany Women Health Therapeutics Market Size, 2017-2028
  6.4.3 France Women Health Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Women Health Therapeutics Market Size, 2017-2028
  6.4.5 Italy Women Health Therapeutics Market Size, 2017-2028
  6.4.6 Russia Women Health Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Women Health Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Women Health Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Women Health Therapeutics Revenue, 2017-2028
  6.5.2 China Women Health Therapeutics Market Size, 2017-2028
  6.5.3 Japan Women Health Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Women Health Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Women Health Therapeutics Market Size, 2017-2028
  6.5.6 India Women Health Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Women Health Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Women Health Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Women Health Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Women Health Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Women Health Therapeutics Market Size, 2017-2028
  6.7.3 Israel Women Health Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Women Health Therapeutics Market Size, 2017-2028
  6.7.5 UAE Women Health Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Women Health Therapeutics Major Product Offerings
  7.1.4 Novartis Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 Abbott
  7.2.1 Abbott Corporate Summary
  7.2.2 Abbott Business Overview
  7.2.3 Abbott Women Health Therapeutics Major Product Offerings
  7.2.4 Abbott Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Abbott Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Women Health Therapeutics Major Product Offerings
  7.3.4 Pfizer Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Eli Lilly
  7.4.1 Eli Lilly Corporate Summary
  7.4.2 Eli Lilly Business Overview
  7.4.3 Eli Lilly Women Health Therapeutics Major Product Offerings
  7.4.4 Eli Lilly Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Eli Lilly Key News
7.5 Bayer
  7.5.1 Bayer Corporate Summary
  7.5.2 Bayer Business Overview
  7.5.3 Bayer Women Health Therapeutics Major Product Offerings
  7.5.4 Bayer Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Bayer Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Women Health Therapeutics Major Product Offerings
  7.6.4 Merck Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche Women Health Therapeutics Major Product Offerings
  7.7.4 Roche Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Roche Key News
7.8 Novo Nordisk
  7.8.1 Novo Nordisk Corporate Summary
  7.8.2 Novo Nordisk Business Overview
  7.8.3 Novo Nordisk Women Health Therapeutics Major Product Offerings
  7.8.4 Novo Nordisk Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Novo Nordisk Key News
7.9 Oasmia
  7.9.1 Oasmia Corporate Summary
  7.9.2 Oasmia Business Overview
  7.9.3 Oasmia Women Health Therapeutics Major Product Offerings
  7.9.4 Oasmia Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Oasmia Key News
7.10 Sanofi
  7.10.1 Sanofi Corporate Summary
  7.10.2 Sanofi Business Overview
  7.10.3 Sanofi Women Health Therapeutics Major Product Offerings
  7.10.4 Sanofi Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Sanofi Key News
7.11 Takeda
  7.11.1 Takeda Corporate Summary
  7.11.2 Takeda Business Overview
  7.11.3 Takeda Women Health Therapeutics Major Product Offerings
  7.11.4 Takeda Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Takeda Key News
7.12 Allergan
  7.12.1 Allergan Corporate Summary
  7.12.2 Allergan Business Overview
  7.12.3 Allergan Women Health Therapeutics Major Product Offerings
  7.12.4 Allergan Women Health Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 Allergan Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Women Health Therapeutics Market Opportunities & Trends in Global Market
Table 2. Women Health Therapeutics Market Drivers in Global Market
Table 3. Women Health Therapeutics Market Restraints in Global Market
Table 4. Key Players of Women Health Therapeutics in Global Market
Table 5. Top Women Health Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Women Health Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Women Health Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Women Health Therapeutics Product Type
Table 9. List of Global Tier 1 Women Health Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Women Health Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Women Health Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Women Health Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Women Health Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Women Health Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Women Health Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Women Health Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Women Health Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Women Health Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Women Health Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Women Health Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Women Health Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Women Health Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Women Health Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Women Health Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Women Health Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Women Health Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Women Health Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Women Health Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Women Health Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Women Health Therapeutics Product Offerings
Table 32. Novartis Women Health Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Corporate Summary
Table 34. Abbott Women Health Therapeutics Product Offerings
Table 35. Abbott Women Health Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Women Health Therapeutics Product Offerings
Table 38. Pfizer Women Health Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Women Health Therapeutics Product Offerings
Table 41. Eli Lilly Women Health Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Bayer Corporate Summary
Table 43. Bayer Women Health Therapeutics Product Offerings
Table 44. Bayer Women Health Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Women Health Therapeutics Product Offerings
Table 47. Merck Women Health Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Women Health Therapeutics Product Offerings
Table 50. Roche Women Health Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Novo Nordisk Corporate Summary
Table 52. Novo Nordisk Women Health Therapeutics Product Offerings
Table 53. Novo Nordisk Women Health Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Oasmia Corporate Summary
Table 55. Oasmia Women Health Therapeutics Product Offerings
Table 56. Oasmia Women Health Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Sanofi Corporate Summary
Table 58. Sanofi Women Health Therapeutics Product Offerings
Table 59. Sanofi Women Health Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Takeda Corporate Summary
Table 61. Takeda Women Health Therapeutics Product Offerings
Table 62. Takeda Women Health Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Allergan Corporate Summary
Table 64. Allergan Women Health Therapeutics Product Offerings
Table 65. Allergan Women Health Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Women Health Therapeutics Segment by Type in 2021
Figure 2. Women Health Therapeutics Segment by Application in 2021
Figure 3. Global Women Health Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Women Health Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Women Health Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Women Health Therapeutics Revenue in 2021
Figure 8. By Type - Global Women Health Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Women Health Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Women Health Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Women Health Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Women Health Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Women Health Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Women Health Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Women Health Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Women Health Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novo Nordisk Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Oasmia Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sanofi Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Takeda Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Allergan Women Health Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)